Author`s Reply
Comment on
-
Brain-derived neurotrophic factor as biomarker.Anatol J Cardiol. 2020 Feb;23(3):192. doi: 10.14744/AnatolJCardiol.2020.84699. Anatol J Cardiol. 2020. PMID: 32120366 Free PMC article. No abstract available.
References
-
- Manni L, Nikolova V, Vyagova D, Chaldakov GN, Aloe L. Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int J Cardiol. 2005;102:169–71. - PubMed
-
- Takashio S, Sugiyama S, Yamamuro M, Takahama H, Hayashi T, Sugano Y, et al. Significance of low plasma levels of brain-derived neurotrophic factor in patients with heart failure. Am J Cardiol. 2015;116:243–9. - PubMed
-
- Fukushima A, Kinugawa S, Homma T, Masaki Y, Furihata T, Yokota T, et al. Serum brain-derived neurotropic factor level predicts adverse clinical outcomes in patients with heart failure. J Card Fail. 2015;21:300–6. - PubMed
-
- Kadowaki S, Shishido T, Honda Y, Narumi T, Otaki Y, Kinoshita D, et al. Additive clinical value of serum brain-derived neurotrophic factor for prediction of chronic heart failure outcome. Heart Vessels. 2016;31:535–44. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources